EFFICACY AND SAFETY OF NIPOCALIMAB, AN FCRN BLOCKER, IN WARM AUTOIMMUNE HEMOLYTIC ANEMIA (WAIHA): ENERGY PHASE 2/3 STUDY DESIGN
a Albert Einstein College of Medicine/Montefiore Medical Center, Department of Hematology and Oncology, New York, United States
b Fondazione IRCCS Ca'Granda Ospedale Maggiore Plicilinico, Hematology Unit, Milan, Italy
c Janssen Global Services, LLC, Cambridge, United States
d Momenta Pharmaceuticals, Inc, Clinical Development Operations, Cambridge, United States
e Immunology Medical Affairs, Janssen Latin America, Bogotá, Colombia
Read
1722
Timeswas read the article
681
Total PDF
1041
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 May | 25 | 9 | 34 |
| 2025 April | 65 | 21 | 86 |
| 2025 March | 67 | 32 | 99 |
| 2025 February | 42 | 28 | 70 |
| 2025 January | 36 | 20 | 56 |
| 2024 December | 39 | 19 | 58 |
| 2024 November | 49 | 23 | 72 |
| 2024 October | 43 | 18 | 61 |
| 2024 September | 57 | 21 | 78 |
| 2024 August | 62 | 31 | 93 |
| 2024 July | 48 | 26 | 74 |
| 2024 June | 56 | 29 | 85 |
| 2024 May | 57 | 23 | 80 |
| 2024 April | 31 | 25 | 56 |
| 2024 March | 36 | 27 | 63 |
| 2024 February | 24 | 26 | 50 |
| 2024 January | 28 | 20 | 48 |
| 2023 December | 35 | 26 | 61 |
| 2023 November | 39 | 33 | 72 |
| 2023 October | 19 | 33 | 52 |
| 2023 September | 24 | 25 | 49 |
| 2023 August | 16 | 14 | 30 |
| 2023 July | 21 | 7 | 28 |
| 2023 June | 17 | 23 | 40 |
| 2023 May | 20 | 14 | 34 |
| 2023 April | 14 | 15 | 29 |
| 2023 March | 12 | 13 | 25 |
| 2023 February | 11 | 17 | 28 |
| 2023 January | 11 | 5 | 16 |
| 2022 December | 23 | 27 | 50 |
| 2022 November | 10 | 23 | 33 |
| 2022 October | 4 | 8 | 12 |
Show all
